awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74
Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74
Post-hemodialysis dosing of 1 vs. 2 g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use.
P2860
Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a5de7679fa297ba3d797a5bb8b03457de0c2adc
P2860
The β-Lactams Strike Back: Ceftazidime-Avibactam